Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
SPRO - NET CHANGE IN CASH
Net Change in Cash SPRO - Spero Therapeutics, Inc.
-32.8 M
LAST VALUE
-48.23%
2 YEAR CAGR
9.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR